Variables | All cases (n = 169) | Imported cases (n = 74) | Local cases (n = 95) | p value |
---|---|---|---|---|
Clinical classification | ||||
Mild type | 10 (5.9) | 5 (6.8) | 5 (5.3) | 0.750 |
Moderate type | 130 (76.9) | 52 (70.3) | 78 (82.1) | 0.097 |
Severe type | 24 (14.2) | 15 (20.3) | 9 (9.5) | 0.074 |
Critical type | 5 (3.0) | 2 (2.7) | 3 (3.2) | 1.000 |
Severe complication | ||||
ARDS | 16 (9.5) | 9 (12.2) | 7 (7.4) | 0.304 |
Shock | 2 (1.2) | 2 (2.7) | 0 (0) | 0.190 |
AKI | 4 (2.4) | 1 (1.4) | 3 (3.2) | 0.632 |
MODS | 3 (1.8) | 1 (1.4) | 2 (2.1) | 1.000 |
Treatments | ||||
Admitted in ICU | 20 (11.8) | 10 (13.5) | 10 (10.5) | 0.634 |
Oxygen therapy | 162 (95.9) | 71 (95.9) | 91 (95.8) | 1.000 |
High-flow nasal cannula oxygen therapy | 14 (8.3) | 7 (9.5) | 7 (7.4) | 0.780 |
Prone Positioning | 4 (2.4) | 2 (2.7) | 2 (2.1) | 1.000 |
Non-invasive positive pressure ventilation | 7 (4.1) | 3 (4.1) | 4 (4.2) | 1.000 |
Invasive positive pressure ventilation | 3 (1.8) | 2 (2.7) | 1 (1.1) | 0.582 |
Extracorporeal membrane oxygenation | 2 (1.2) | 2 (2.7) | 0 (0) | 0.190 |
Continuous renal replacement therapy | 1 (0.6) | 1 (1.4) | 0 (0) | 0.438 |
Antiviral treatment | ||||
Monotherapy | 41 (24.3) | 16 (21.6) | 25 (26.3) | 0.588 |
Combination therapy | 128 (75.7) | 58 (78.4) | 70 (73.7) | 0.588 |
Antibiotic treatment | 87 (51.5) | 45 (60.8) | 43 (44.2) | 0.043 |
Glucocorticoids | 44 (26.0) | 27 (36.5) | 17 (17.9) | 0.008 |
Course of treatment (days) -Median (IQR) | 7 (5–9) | 7 (5–10) | 6 (4–8.5) | 0.259 |
Gamma globulin | 44 (26.0) | 27 (36.5) | 17 (17.9) | 0.008 |
Course of treatment (days)-Median (IQR) | 6 (4–8) | 6 (4–7) | 6 (3.5–8.5) | 0.913 |
Clinical outcome | ||||
Discharged from hospital | 154 (91.1) | 72 (97.3) | 82 (86.3) | 0.002 |
Death | 1 (0.6) | 1 (1.4) | 0 (0) | |
Hospitalization | 14 (8.3) | 1 (1.4) | 13 (13.7) | |
Length of hospital stay (days) | 13 (11.0–18.0) | 13 (11.0–17.8) | 13 (10.0–19.0) | 0.916 |
Viral clearance duration (days) a | ||||
Median (IQR) | 10 (8–15) | 11 (8–15) | 9 (7–15) | 0.080 |